Jeremy Roach

Title: The Innovations of Jeremy Roach

Introduction

Jeremy Roach is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target the kappa-opioid receptor. His work has implications for treating various medical conditions, including pain and depression.

Latest Patents

Jeremy Roach holds a patent for the synthesis of 20-nor-salvinorin A. This invention provides an analog of the kappa-opioid agonist salvinorin A. The 20-nor-salvinorin A is an active kappa-opioid modulator and can be used for the treatment of medical conditions wherein modulation of the kappa-opioid receptor is medically indicated. These conditions include pain, pruritis, depression, and inflammation, as well as issues related to perception and consciousness. Notably, 20-nor-salvinorin A can be less addictive when used in treatment compared to a mu-opioid receptor agonist. Additionally, it is more stable in vivo than its parent compound, salvinorin A. The patent also provides synthetic intermediates and procedures for the preparation of 20-nor-salvinorin A.

Career Highlights

Jeremy Roach is affiliated with The Scripps Research Institute, where he conducts his research. His work has garnered attention for its potential to improve therapeutic options for patients suffering from various conditions.

Collaborations

He has collaborated with notable researchers, including Ryan Shenvi and Yusuke Sasano, to advance his work in the field.

Conclusion

Jeremy Roach's innovative contributions to medicinal chemistry, particularly through his patent on 20-nor-salvinorin A, highlight his role as a significant inventor in the field. His work continues to pave the way for new treatment options that may benefit many patients.